These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 17704247
1. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells. Kim KI, Kang JH, Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC. J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247 [Abstract] [Full Text] [Related]
2. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells. Li W, Tan J, Wang P, Wu P. Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672 [Abstract] [Full Text] [Related]
3. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma. Kim JE, Ahn BC, Hwang MH, Jeon YH, Jeong SY, Lee SW, Lee J. J Nucl Med; 2011 Nov; 52(11):1756-63. PubMed ID: 21994409 [Abstract] [Full Text] [Related]
4. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter. Park SY, Kwak W, Thapa N, Jung MY, Nam JO, So IS, Kim SY, Yoo J, Lee J, Kim IS. J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598 [Abstract] [Full Text] [Related]
5. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C. Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175 [Abstract] [Full Text] [Related]
6. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Cancer Res; 2003 Nov 15; 63(22):7840-4. PubMed ID: 14633711 [Abstract] [Full Text] [Related]
7. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma. Ma XJ, Huang R, Kuang AR. Cancer Invest; 2009 Jul 15; 27(6):673-81. PubMed ID: 19241193 [Abstract] [Full Text] [Related]
8. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma. Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Romijn JA, van der Heide D. Exp Clin Endocrinol Diabetes; 2001 Jul 15; 109(1):52-5. PubMed ID: 11573141 [Abstract] [Full Text] [Related]
10. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells. Haberkorn U, Beuter P, Kübler W, Eskerski H, Eisenhut M, Kinscherf R, Zitzmann S, Strauss LG, Dimitrakopoulou-Strauss A, Altmann A. J Nucl Med; 2004 May 15; 45(5):827-33. PubMed ID: 15136633 [Abstract] [Full Text] [Related]
15. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. Cancer Res; 2000 Nov 15; 60(22):6526-30. PubMed ID: 11103823 [Abstract] [Full Text] [Related]